EP3265454

TGF-BETA INHIBITORS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    26.2.2016
  • EP published:
    26.2.2020
  • EP application number:
    16710547.7
  • Max expiry date:
    25.2.2036
  • Title:
    TGF-BETA INHIBITORS

Timeline

Today
26.2.2016EP application
26.2.2020EP Publication

Owner

  • Name:
    Rigel Pharmaceuticals, Inc.
  • Address:
    1180 Veterans Boulevard, South San Francisco, CA 94080, US
  • Name:
    Bristol-Myers Squibb Company
  • Address:
    Route 206 and Province Line Road, Princeton, NJ 08543, US

Inventor

  • Name:
    KINSELLA, Todd
  • Address:
    Redwood City, CA 94061, US
  • Name:
    GELMAN, Marina
  • Address:
    San Francisco, CA 94121, US
  • Name:
    HONG, Hui
  • Address:
    Foster City, CA 94404, US
  • Name:
    DARWISH, Ihab, S.
  • Address:
    San Carlos, CA 94070, US
  • Name:
    SINGH, Rajinder
  • Address:
    Belmont, CA 94002, US
  • Name:
    YU, Jiaxin
  • Address:
    San Carlos, CA 94070, US
  • Name:
    BORZILLERI, Robert, M.
  • Address:
    Princeton, NJ 08543, US
  • Name:
    VELAPARTHI, Upender
  • Address:
    Wallingford, CT 06492, US
  • Name:
    LIU, Peiying
  • Address:
    Wallingford CT 06492, US
  • Name:
    DARNE, Chetan
  • Address:
    Wallingford, CT 06492, US
  • Name:
    RAHAMAN, Hasibur
  • Address:
    Bangalore 560100, IN
  • Name:
    WARRIER, Jayakumar, Sankara
  • Address:
    Bangalore 560068, IN

Priority

  • Number:
    201562127109 P
  • Date:
    2.3.2015
  • Country:
    US

Classification

  • Categories:
    C07D 401/04, C07D 403/04, C07D 417/04, C07D 471/04, C07D 487/04, A61K 31/4164, A61K 31/426, A61P 35/00

Upload documents